Appointment Supports Advancement of Company’s Strategic Priorities and Organizational Growth with Lead Asset Solrikitug in Phase II Trials Uniquity Bio, a clinical-stage drug development company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of Kelderman's pay was in ...

Tevogen Bio, a clinical-stage immunotherapy biotech company led by CEO Ryan Saadi, is reaffirming its commitment to shareholder equity amid discussions on financing strategies in the industry. Dr.

• Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President For more information, please visit www.generationbio.com. Forward-Looking StatementsAny statements in this press release ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Raising money to advance promising science is a constant struggle, bringing biopharma executive leadership together to learn about investment strategies in the opening session at the Biotechnology ...

Former Rappta Therapeutics CEO and Ipsen Global Oncology Franchise Head joins as TREOS advances its off-the-shelf, ...

BridgeBio CEO Neil Kumar joins CNBC's 'Power Lunch' to discuss the company's latest drug developments, how the drugs compares to competitors in the space, and more. Got a confidential news tip? We ...

Ilan Sobel has been the CEO of BioHarvest Sciences Inc. since July 2020. He brought the company’s first product, VINIA, to North America, building a direct-to-consumer machine that is now generating ...